Enhabit Inc (EHAB)

$10.76

+0.02

(+0.19%)

Market is closed - opens 8 PM, 07 Dec 2023

Insights on Enhabit Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 275.1M → 258.3M (in $), with an average decrease of 3.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -74.4M → -2.4M (in $), with an average increase of 3000.0% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 41.7% return, outperforming this stock by 68.1%

Performance

  • $10.74
    $11.11
    $10.76
    downward going graph

    0.19%

    Downside

    Day's Volatility :3.33%

    Upside

    3.15%

    downward going graph
  • $7.12
    $16.64
    $10.76
    downward going graph

    33.83%

    Downside

    52 Weeks Volatility :57.21%

    Upside

    35.34%

    downward going graph

Returns

PeriodEnhabit IncIndex (Russel 2000)
3 Months
-13.6%
0.0%
6 Months
-21.2%
0.0%
1 Year
-26.44%
-2.4%
3 Years
-52.77%
-6.5%

Highlights

Market Capitalization
547.9M
Book Value
$13.51
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-3.39
Wall Street Target Price
10.25
Profit Margin
-16.14%
Operating Margin TTM
3.02%
Return On Assets TTM
2.05%
Return On Equity TTM
-21.27%
Revenue TTM
1.0B
Revenue Per Share TTM
21.04
Quarterly Revenue Growth YOY
-2.8000000000000003%
Gross Profit TTM
545.5M
EBITDA
81.8M
Diluted Eps TTM
-3.39
Quarterly Earnings Growth YOY
-0.9
EPS Estimate Current Year
0.18
EPS Estimate Next Year
0.22
EPS Estimate Current Quarter
0.07
EPS Estimate Next Quarter
0.12

Analyst Recommendation

Sell
    8%Buy
    41%Hold
    50%Sell
Based on 12 Wall street analysts offering stock ratings for Enhabit Inc(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
5
5
7
Sell
6
6
6

Analyst Forecast

What analysts predicted

Downside of 4.74%

Current $10.76
Target $10.25

Company Financials

FY19Y/Y Change
Revenue
1.1B
-
Net Income
24.0M
-
Net Profit Margin
2.2%
-
FY20Y/Y Change
Revenue
1.1B
↓ 1.26%
Net Income
75.0M
↑ 212.5%
Net Profit Margin
6.96%
↑ 4.76%
FY21Y/Y Change
Revenue
1.1B
↑ 2.63%
Net Income
111.1M
↑ 48.13%
Net Profit Margin
10.04%
↑ 3.08%
FY22Y/Y Change
Revenue
1.1B
↓ 2.12%
Net Income
62.5M
↓ 43.74%
Net Profit Margin
5.77%
↓ 4.27%
Q2 FY22Q/Q Change
Revenue
268.0M
↓ 2.3%
Net Income
20.1M
↓ 22.99%
Net Profit Margin
7.5%
↓ 2.02%
Q3 FY22Q/Q Change
Revenue
265.7M
↓ 0.86%
Net Income
8.6M
↓ 57.21%
Net Profit Margin
3.24%
↓ 4.26%
Q4 FY22Q/Q Change
Revenue
275.1M
↑ 3.54%
Net Income
7.7M
↓ 10.47%
Net Profit Margin
2.8%
↓ 0.44%
Q1 FY23Q/Q Change
Revenue
275.1M
↑ 0.0%
Net Income
7.7M
↑ 0.0%
Net Profit Margin
2.8%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
262.3M
↓ 4.65%
Net Income
-74.4M
↓ 1066.23%
Net Profit Margin
-28.36%
↓ 31.16%
Q3 FY23Q/Q Change
Revenue
258.3M
↓ 1.52%
Net Income
-2.4M
↓ 96.77%
Net Profit Margin
-0.93%
↑ 27.43%
FY20Y/Y Change
Total Assets
1.6B
-
Total Liabilities
227.0M
-
FY21Y/Y Change
Total Assets
1.7B
↑ 6.38%
Total Liabilities
236.7M
↑ 4.27%
FY22Y/Y Change
Total Assets
1.6B
↓ 4.33%
Total Liabilities
767.3M
↑ 224.17%
Q2 FY22Q/Q Change
Total Assets
1.6B
↓ 6.99%
Total Liabilities
765.5M
↑ 216.06%
Q3 FY22Q/Q Change
Total Assets
1.6B
↑ 0.09%
Total Liabilities
108.0M
↓ 85.89%
Q4 FY22Q/Q Change
Total Assets
1.6B
↑ 1.4%
Total Liabilities
772.6M
↑ 615.37%
Q1 FY23Q/Q Change
Total Assets
1.6B
↑ 0.0%
Total Liabilities
767.3M
↓ 0.69%
Q2 FY23Q/Q Change
Total Assets
1.4B
↓ 13.33%
Total Liabilities
719.0M
↓ 6.29%
Q3 FY23Q/Q Change
Total Assets
1.5B
↑ 1.73%
Total Liabilities
742.1M
↑ 3.21%
FY19Y/Y Change
Operating Cash Flow
59.5M
-
Investing Cash Flow
-246.0M
-
Financing Cash Flow
198.2M
-
FY20Y/Y Change
Operating Cash Flow
24.9M
↓ 58.15%
Investing Cash Flow
-3.0M
↓ 98.78%
Financing Cash Flow
-16.7M
↓ 108.43%
FY21Y/Y Change
Operating Cash Flow
123.3M
↑ 395.18%
Investing Cash Flow
-119.2M
↑ 3873.33%
Financing Cash Flow
-36.1M
↑ 116.17%
FY22Y/Y Change
Operating Cash Flow
80.1M
↓ 35.04%
Investing Cash Flow
-42.3M
↓ 64.51%
Financing Cash Flow
-18.6M
↓ 48.48%
Q2 FY22Q/Q Change
Operating Cash Flow
33.6M
↓ 18.84%
Investing Cash Flow
-2.1M
↑ 50.0%
Financing Cash Flow
1000.0K
↓ 103.73%
Q3 FY22Q/Q Change
Operating Cash Flow
1000.0K
↓ 97.02%
Investing Cash Flow
-600.0K
↓ 71.43%
Financing Cash Flow
-6.2M
↓ 720.0%
Q4 FY22Q/Q Change
Operating Cash Flow
4.1M
↑ 310.0%
Investing Cash Flow
-38.2M
↑ 6266.67%
Financing Cash Flow
13.4M
↓ 316.13%
Q1 FY23Q/Q Change
Operating Cash Flow
4.1M
↑ 0.0%
Investing Cash Flow
-3.2M
↓ 91.62%
Financing Cash Flow
13.4M
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
9.6M
↑ 134.15%
Investing Cash Flow
-800.0K
↓ 75.0%
Financing Cash Flow
-11.9M
↓ 188.81%

Technicals Summary

Sell

Neutral

Buy

Enhabit Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Enhabit Inc
Enhabit Inc
26.35%
-21.2%
-26.44%
-52.77%
-52.77%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
19.93%
-8.67%
30.55%
-51.05%
-48.15%
Hca Holdings, Inc.
Hca Holdings, Inc.
9.31%
-6.89%
6.72%
62.52%
79.28%
Universal Health Services Inc.
Universal Health Services Inc.
4.97%
0.07%
6.38%
3.88%
3.4%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
32.47%
5.37%
41.69%
-3.55%
69.22%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Enhabit Inc
Enhabit Inc
9.84
NA
NA
0.18
-0.21
0.02
0.0
13.51
Fresenius Medical Care Ag
Fresenius Medical Care Ag
24.98
24.98
0.88
1.94
0.04
0.02
0.03
47.74
Hca Holdings, Inc.
Hca Holdings, Inc.
12.47
12.47
1.31
18.2
0.21
0.11
0.01
-9.21
Universal Health Services Inc.
Universal Health Services Inc.
14.46
14.46
1.87
10.3
0.11
0.05
0.01
88.85
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.2
16.2
0.43
7.83
0.34
0.05
0.11
13.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Enhabit Inc
Enhabit Inc
Sell
$547.9M
-52.77%
9.84
-16.14%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$12.4B
-48.15%
24.98
2.31%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$67.5B
79.28%
12.47
9.05%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$9.4B
3.4%
14.46
4.82%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$9.5B
69.22%
16.2
5.11%

Institutional Holdings

  • BlackRock Inc

    16.29%
  • Vanguard Group Inc

    11.52%
  • Deerfield Management Co

    9.60%
  • JANA Partners LLC

    4.94%
  • AREX CAPITAL MANAGEMENT, LP

    4.56%
  • Cruiser Capital Advisors, LLC

    4.11%

Company Information

Organization
Enhabit Inc
Employees
10000
CEO
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
Industry
Healthcare

FAQs